Stock Evaluator: Novozymes A/S (NVZMY)

Novozymes A/S NVZMY

$65.04 -0.79 -1.20%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 18,199
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD | DELAYED PRICE
SECTOR INDUSTRY
Materials Chemicals

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women’s, children’s cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.

Financial Summary

Share Statistics NVZMY Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $30,263.8 $3,722.6 90%
Shares Out (Mil) 538.7 87.3 89%
Institutional Ownership 50.0% 87.5% 30%
Float (Mil) 346.6 117.5 81%
Beta 0.63 0.80 36%
Avg Daily Volume (000s) 25 176 22%
Price Change
(52-week)
(1.4%) 81.7% 44%
Growth NVZMY Industry
Median
Percentile
(All Stocks)
Sales (5yr) 16.2% 4.2% 75%
Net Income (5yr) 8.1% 1.4% 52%
EPS (5yr) (2.3%) 3.2% 28
Dividends (5yr) 3.4% 0.0% 79%
Cash Flow (5yr) (14.9%) (15.3%) 53%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials NVZMY Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $4,842 $3,981 74%
Net Income (TTM) (Mil) $688 $70 83%
EPS (TTM) $1.474 $0.400 66%
Operating Cash Flow (TTM) (Mil) $1,478 $388 85%
Net Cash Flow (TTM) (Mil) $90 $9 76%
Long-Term Debt (Q1) (Mil) $3,371 $1,682 81%
Enterprise Value (Q1) (Mil) $30,270 $5,497 88%
Valuation NVZMY Industry
Median
Percentile
(All Stocks)
P/B na 1.48 na
P/E na 24.8 na
Dividend Yield na 1.3% na
PEG (5yr hist) na 2.0 na
Ratios NVZMY Industry
Median
Percentile
(All Stocks)
Gross Margin 55.9% 29.8% 68%
Net Margin 14.2% 2.8% 71%
ROA 3.9% 2.1% 67%
ROE 5.6% 4.8% 45%
Liabilities to Assets 33.9% 53.6% 25%
F-Score na 5 na

Novozymes A/S did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors